GSA Capital Partners LLP Invests $1.46 Million in Viemed Healthcare, Inc. $VMD

GSA Capital Partners LLP acquired a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) during the second quarter, according to its most recent disclosure with the SEC. The fund acquired 127,591 shares of the company’s stock, valued at approximately $1,455,000. GSA Capital Partners LLP owned approximately 0.33% of Viemed Healthcare as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Arrowstreet Capital Limited Partnership raised its stake in Viemed Healthcare by 101.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after acquiring an additional 358,863 shares during the period. Wasatch Advisors LP lifted its holdings in Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock valued at $10,683,000 after purchasing an additional 240,346 shares in the last quarter. Hillsdale Investment Management Inc. purchased a new position in Viemed Healthcare during the first quarter valued at approximately $1,834,000. Two Sigma Investments LP boosted its position in shares of Viemed Healthcare by 193.7% in the third quarter. Two Sigma Investments LP now owns 251,410 shares of the company’s stock worth $1,707,000 after purchasing an additional 165,797 shares during the period. Finally, Rothschild Wealth LLC bought a new position in shares of Viemed Healthcare in the fourth quarter worth approximately $967,000. 74.24% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have recently commented on VMD shares. Weiss Ratings upgraded shares of Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, August 3rd. Wall Street Zen downgraded shares of Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday. Finally, Freedom Capital lowered Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, Viemed Healthcare has a consensus rating of “Hold”.

Viemed Healthcare Price Performance

NASDAQ VMD opened at $9.20 on Monday. Viemed Healthcare, Inc. has a 12 month low of $6.05 and a 12 month high of $12.61. The company has a current ratio of 1.13, a quick ratio of 1.02 and a debt-to-equity ratio of 0.04. The stock has a market cap of $350.43 million, a PE ratio of 25.56 and a beta of 1.10. The stock’s 50 day moving average is $11.10 and its 200 day moving average is $9.83.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). The company had revenue of $78.10 million for the quarter, compared to analysts’ expectations of $78.00 million. Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. Research analysts predict that Viemed Healthcare, Inc. will post 0.42 EPS for the current fiscal year.

Insiders Place Their Bets

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of Viemed Healthcare stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the sale, the director directly owned 75,518 shares in the company, valued at approximately $868,457. The trade was a 20.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider William Frazier sold 10,000 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the sale, the insider owned 73,214 shares in the company, valued at approximately $858,068.08. The trade was a 12.02% decrease in their position. The SEC filing for this sale provides additional information. 20.60% of the stock is currently owned by corporate insiders.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.